Repository hosted by TU Delft Library

Home · Contact · About · Disclaimer ·
 

Improvement of the Cramer classification for oral exposure using the database TTC RepDose - A strategy description

Publication files not online:

Author: Tluczkiewicz, I. · Buist, H.E. · Martin, M.T. · Mangelsdorf, I. · Escher, S.E.
Type:article
Date:2011
Source:Regulatory Toxicology and Pharmacology, 3, 61, 340-350
Identifier: 442930
doi: doi:10.1016/j.yrtph.2011.09.005
Keywords: Nutrition · Cramer classification · Database · Oral exposure · Refinement · RepDose · Risk assessment · SAR · Structure activity relationship · Threshold of toxicological concern · Toxicology · TTC concept · Life · QS - Quality & Safety · EELS - Earth, Environmental and Life Sciences

Abstract

The present report describes a strategy to refine the current Cramer classification of the TTC concept using a broad database (DB) termed TTC RepDose. Cramer classes 1-3 overlap to some extent, indicating a need for a better separation of structural classes likely to be toxic, moderately toxic or of low toxicity.Groups of structurally similar compounds of high toxicity in Cramer class 1 and of moderate to low toxicity in Cramer class 3 were identified and reassigned to the appropriate Cramer class according to their observed toxicological potency in in vivo studies. This refinement results in a better discrimination of Cramer classes 1 and 3 and an increased number of substances in Cramer class 2. The TTC values are 8.7 µmol/person/d (class 1), 6.72 µmol/person/d (class 2) and 0.28µmol/person/d (class 3). Assuming a median molecular weight of 220. g/mol for the compounds of the TTC RepDose DB, the corresponding TTC values are 1930, 1478 and 63 µg/person/d for classes 1, 2 and 3 respectively. The derived thresholds are close to the TTC values initially proposed by Munro with 1800, 540 and 90 µg/person/d for classes 1, 2 and 3 respectively. Additional structural classes are discussed with a view to further refinement of the current Cramer classification scheme. © 2011 Elsevier Inc.